Berney, Michael
- Albert Einstein College of Medicine (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,827
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$2M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#3,827
By linked amount among FY2023 PIs
Earliest Year Loaded
2016
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Berney, Michael as a PI. Multi-PI records show the full award amount for context.
- 1R01AI173328-01R01Contact PIIdentification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling$653.8Kaward amount
- 5R01AI139465-06R01Contact PIEradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases$631Kaward amount
- $501.8Kaward amount
- 5R21AI159348-02R21Contact PICoenzyme F420, helping mycobacteria find a niche in humans$198Kaward amount
Award organization
Organizations that administered FY2023 awards listing Berney, Michael as a PI.
FY2023 award administered by Albert Einstein College of Medicine (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardAlbert Einstein College of Medicine
- 2018$500K Cumulative Funding
- 2018R01 Grant Holder
- 2019$1M Cumulative Funding
- 2019Entered Top 50% NationallyRanked #9729
- 2020$2M Cumulative Funding
- 2023$5M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #3827